CERS has been granted a new patent
Nov 27, 2024, 11:32 PM
-8.79%
What does CERS do
Cerus, headquartered in Concord, California, focuses on developing the INTERCEPT Blood System to enhance blood safety by reducing pathogens in transfusion blood components. The company employs 288 people and specializes in various blood products.
CERS filed a patent for "biological fluid treatment systems" on Mon, April 29, 2024. The patent was officially published on Thu, October 24, 2024.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.